Kalliopi Fragiadaki

Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: An open‐label trial

Petros P. Sfikakis, John Boletis, Sophia Lionaki et al. · Arthritis & Rheumatism · 2005 · 413 citations

Life Sciences, Immunology, Pharmacotherapy +17

Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis

Petros P. Sfikakis, Vassilis L. Souliotis, Kalliopi Fragiadaki et al. · Clinical Immunology · 2007 · 200 citations

Life Sciences, Immunology, Nephrology +17

A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behcet's disease: a comparative 4-week study

Nikos N. Markomichelakis, E. Delicha, S. Masselos et al. · Lara D. Veeken · 2010 · 119 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16

Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis

Petros P. Sfikakis, C. Papamichael, Kimon Stamatelopoulos et al. · Arthritis & Rheumatism · 2007 · 99 citations

Medicine, Pharmacotherapy, Cardiovascular Pharmacotherapy +14

Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.

Evangelos Terpos, Kalliopi Fragiadaki, Maria Konsta et al. · PubMed · 2012 · 83 citations

Medicine, Immunology, Pharmacotherapy +17